Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "biosimilars-revenue"

2 News Found

Biocon Q4 profit jumps 64%; FY26 revenue crosses Rs. 16,900 crore
Biopharma | May 08, 2026

Biocon Q4 profit jumps 64%; FY26 revenue crosses Rs. 16,900 crore

Among the growth drivers are biosimilars business, operational efficiencies, and integration of biosimilars and generics operations


Biocon Q1 FY26 PAT slips 95% to Rs. 31.4 Cr
News | August 08, 2025

Biocon Q1 FY26 PAT slips 95% to Rs. 31.4 Cr

Revenue from operations rose 14.8 per cent year-on-year to Rs. 3,942 crore